BIOCRYST PHARMACEUTICALS, INC. Operating Leases, Future Minimum Payments, Due in Three Years
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Operating Leases, Future Minimum Payments, Due in Three Years of $524.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-03-14
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $524.00K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $862.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $822.00K.
- 2014-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $870.00K; Operating Leases, Future Minimum Payments, Due in Three Years as first filed $384.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years | Operating Leases, Future Minimum Payments, Due in Three Years as first filed |
|---|---|---|
| 2018-12-31 | $524.00K 10-K · filed 2019-03-14 | |
| 2017-12-31 | $862.00K 10-K · filed 2018-03-12 | |
| 2016-12-31 | $822.00K 10-K · filed 2017-02-27 | |
| 2014-12-31 | $870.00K 10-K · filed 2016-02-26 | $384.00K 10-K · filed 2015-03-02 |
| 2012-12-31 | $370.00K 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |